HomeNewsBusinessWockhardt to exit US generic pharma segment to unlock capital for high-impact areas

Wockhardt to exit US generic pharma segment to unlock capital for high-impact areas

Continuing US generic operations would detract company from innovation agenda, says Wockhardt

July 11, 2025 / 16:38 IST
Story continues below Advertisement
Wockhardt to exit US generic pharma segment to unlock capital for high-impact areas
Wockhardt to exit US generic pharma segment to unlock capital for high-impact areas
Moneycontrol News
first published: Jul 11, 2025 04:38 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!